Komori
Other Disclosures2158FRONTEO,Inc.Information and Communications, Services and Others

FRONTEO's medical literature search AI, "KIBIT Amanogawa," adopted by Suntory Global Innovation Center

Suntory Global Innovation Center adopted FRONTEO’s medical literature search AI “KIBIT Amanogawa” for research activities. It will use the AI to identify new ideas and hypotheses in the food and health fields from medical and life sciences papers.

Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
40000000
papers+
Wording
Conditional
How definitive the wording is.

Announced details

KIBIT Amanogawa
Applicable field (uses covered by this announcement)
Food and health researchMedical and life sciences research
Launch dateAlready introduced (specific date: Not disclosed)
What the company reported numerically
Usage history

Analyses more than 40 million papers in the medical and life sciences fields

Relationship between the counterparty and the company
FRONTEO,Inc.2158
Relationship with the Company

A business relationship in which Suntory Global Innovation Center adopts the medical literature search AI provided by FRONTEO. Capital and personnel relationships: Not disclosed.

CounterpartySuntory Global Innovation Center Ltd.

Head office: Minato-ku, Tokyo; President and Representative Director: Takemoto Susumu (竹本 晋). The company is responsible for research and technology development aimed at enhancing the value and driving the growth of the Suntory Group as a whole.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredKIBIT Amanogawa
CounterpartySuntory Global Innovation Center Ltd.
Counterparty overviewHead office: Minato-ku, Tokyo; President and Representative Director: Takemoto Susumu (竹本 晋). The company is responsible for research and technology development aimed at enhancing the value and driving the growth of the Suntory Group as a whole.
Relationship with the CompanyA business relationship in which Suntory Global Innovation Center adopts the medical literature search AI provided by FRONTEO. Capital and personnel relationships: Not disclosed.
Launch dateAlready introduced (specific date: Not disclosed)
Applicable areaFood and health research, Medical and life sciences research
Usage historyAnalyses more than 40 million papers in the medical and life sciences fields
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To use it in research activities to identify new ideas and hypotheses from medical and life sciences papers.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FRONTEO's medical literature search AI, "KIBIT Amanogawa," adopted by Suntory Global Innovation Center | FRONTEO,Inc. (2158) timely disclosure | Komori